FDA Drug recall D-0290-2021
Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Wi…
- FDA Drug
- Class II
- terminated
- Published 2021-03-10
On 2021-03-10 the FDA classified a Class II recall of Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Wi… by Aurobindo Pharma Usa, citing presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0290-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-01-20 |
| Published | 2021-03-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Aurobindo Pharma Usa |
| Distribution | CA, GA, PA, TX |
Product
Famotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India, NDC 65862-860-99
Reason
Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.
Identifiers
| ndc | 65862-859-30 |
|---|---|
| ndc | 65862-859-01 |
| ndc | 65862-859-05 |
| ndc | 65862-859-99 |
| ndc | 65862-859-10 |
| ndc | 65862-859-78 |
| ndc | 65862-860-30 |
| ndc | 65862-860-01 |
| ndc | 65862-860-05 |
| ndc | 65862-860-99 |
| ndc | 65862-860-10 |
| ndc | 65862-860-78 |
| code_info | Lot #: P2000467, Exp 7/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0290-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.